Matches in Wikidata for { <http://www.wikidata.org/entity/Q57217676> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q57217676 description "article" @default.
- Q57217676 description "im Dezember 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57217676 description "wetenschappelijk artikel" @default.
- Q57217676 description "наукова стаття, опублікована в лютому 2011" @default.
- Q57217676 name "Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies" @default.
- Q57217676 name "Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies" @default.
- Q57217676 type Item @default.
- Q57217676 label "Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies" @default.
- Q57217676 label "Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies" @default.
- Q57217676 prefLabel "Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies" @default.
- Q57217676 prefLabel "Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies" @default.
- Q57217676 P1433 Q57217676-78307BF0-F550-40E3-A2F5-96C8EC102731 @default.
- Q57217676 P1476 Q57217676-59775EBE-E11D-4A4F-8E13-6488694C9072 @default.
- Q57217676 P2093 Q57217676-07BCF3A6-B936-4633-932C-B62DD1B0C757 @default.
- Q57217676 P2093 Q57217676-5453D90A-00D4-4761-AC84-AC5B104F638A @default.
- Q57217676 P2093 Q57217676-7083D11F-4F09-4F8F-850E-DFA2E4BAE221 @default.
- Q57217676 P2093 Q57217676-907A460B-D6A9-49A5-8847-9E94380E855B @default.
- Q57217676 P2093 Q57217676-99B7449B-D10E-4BC8-8C09-EBB0D202B333 @default.
- Q57217676 P2093 Q57217676-A76B5046-5C23-4B4E-ACF3-D42F0993DF02 @default.
- Q57217676 P2093 Q57217676-A7CB7262-F5A5-42AE-8373-8A1FE010B386 @default.
- Q57217676 P2093 Q57217676-BCC95A26-D702-48A2-86D4-E9819982169F @default.
- Q57217676 P304 Q57217676-E2297C05-8A9D-4EEA-8AD2-3D52699A7A8D @default.
- Q57217676 P31 Q57217676-9178018D-A53B-4778-BB06-F1A96C346E0D @default.
- Q57217676 P356 Q57217676-BC8B5981-7B94-4F22-8082-652A7A2251D5 @default.
- Q57217676 P433 Q57217676-3D4B098A-B337-4428-981F-8961E15F01E3 @default.
- Q57217676 P478 Q57217676-7E0A385D-ADF2-4D51-B049-76819E026721 @default.
- Q57217676 P50 Q57217676-12DAC5B1-6C7A-4C7E-AF7C-BD1EF6B53FE0 @default.
- Q57217676 P50 Q57217676-20CF3863-B42D-435D-A987-5A39D761A119 @default.
- Q57217676 P50 Q57217676-6192A44D-9746-40E0-9A89-BD8E6F87D6CE @default.
- Q57217676 P50 Q57217676-8F150A51-3EA0-4E49-9BB2-174DF7E132CD @default.
- Q57217676 P50 Q57217676-96479FB4-973D-457C-8B50-B4D18021626C @default.
- Q57217676 P50 Q57217676-9B705BEB-8960-46E9-906B-7DA1796C5E16 @default.
- Q57217676 P50 Q57217676-A8E6AA86-44F6-4970-BD85-686F94BC91D0 @default.
- Q57217676 P50 Q57217676-D1295E2F-777C-468A-A41B-2E59A5B9B877 @default.
- Q57217676 P577 Q57217676-9A046A24-A1AE-45B1-A810-3918C32A88D5 @default.
- Q57217676 P698 Q57217676-D0687657-0E4F-4C38-A14C-976EAA9BA087 @default.
- Q57217676 P921 Q57217676-6A628053-C008-40D8-8081-9ADA0A8BAE34 @default.
- Q57217676 P356 J.JAUT.2010.09.006 @default.
- Q57217676 P698 20970960 @default.
- Q57217676 P1433 Q15716783 @default.
- Q57217676 P1476 "Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies" @default.
- Q57217676 P2093 "Emilie M Fournier" @default.
- Q57217676 P2093 "Eric Oksenhendler" @default.
- Q57217676 P2093 "Jagadeesh Bayry" @default.
- Q57217676 P2093 "Janakiraman Vani" @default.
- Q57217676 P2093 "Luc Mouthon" @default.
- Q57217676 P2093 "Mikael Berdah" @default.
- Q57217676 P2093 "Yoann Crabol" @default.
- Q57217676 P2093 "Yves Lévy" @default.
- Q57217676 P304 "9-15" @default.
- Q57217676 P31 Q13442814 @default.
- Q57217676 P356 "10.1016/J.JAUT.2010.09.006" @default.
- Q57217676 P433 "1" @default.
- Q57217676 P478 "36" @default.
- Q57217676 P50 Q28322530 @default.
- Q57217676 P50 Q40020459 @default.
- Q57217676 P50 Q42325557 @default.
- Q57217676 P50 Q43101046 @default.
- Q57217676 P50 Q43707555 @default.
- Q57217676 P50 Q43707567 @default.
- Q57217676 P50 Q47504197 @default.
- Q57217676 P50 Q55297957 @default.
- Q57217676 P577 "2010-12-09T00:00:00Z" @default.
- Q57217676 P698 "20970960" @default.
- Q57217676 P921 Q1472818 @default.